Paper39486371
Comparative study on physicochemical characterization and immunomodulatory activities of neutral and acidic Lycium barbarum polysaccharides.
Duan JL and 11 others. Biomed Pharmacother, 2024. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. Comparative study on physicochemical characterization and immunomodulatory activities of neutral and acidic Lycium barbarum polysaccharides. Papers, record 39486371. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39486371
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparative study on physicochemical characterization and immunomodulatory activities of neutral and acidic Lycium barbarum polysaccharides.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mice, Inbred C57BL | Major topic |
| Drugs, Chinese Herbal | Major topic |
| Macrophages | Major topic |
| Melanoma, Experimental | Major topic |
| Animals | |
| Mice | |
| Immunologic Factors | |
| Male | |
| Dendritic Cells | |
| Cell Line, Tumor | |
| Lycium | |
| RAW 264.7 Cells | |
| Immunomodulating Agents |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42683198 | Natural Medicines Modulating Tumor Perineural Invasion: Regulatory Mechanisms and Therapeutic Potential. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42683198 | PubMed |
| 42073349 | Plant-Based Biomaterials as Bio-Instructive Immunomodulators: Design Principles, Mechanisms, and Translational Challenges. | Life (Basel) | 2026 | https://conductscience.org/library/papers/42073349 | PubMed |
| 42039268 | An oral immune enhancer with excellent biocompatibility for effectively strengthening body's immunity and treating cancer. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42039268 | PubMed |
| 41977263 | The Influence of Monosaccharide Composition on the Bioactivity of Medicinal Plant Polysaccharides. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41977263 | PubMed |
| 41751457 | Walnut Green Husk Polysaccharide Improve Gut Microbiota and Alleviate Intestinal Inflammation Caused by Immune Checkpoint Inhibitors. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/41751457 | PubMed |
| 41700132 | Lycium barbarum Polysaccharide Alleviates Renal Damage in Mouse Sepsis by Regulating M1/M2 Macrophage Polarization. | Food Sci Nutr | 2026 | https://conductscience.org/library/papers/41700132 | PubMed |
| 41459531 | Targeting the TLR4 axis with microbiota-oriented interventions and innovations in diabetes therapy: a narrative review. | Front Immunol | 2025 | https://conductscience.org/library/papers/41459531 | PubMed |
| 41050703 | Regulatory effects of Lycium Barbarum polysaccharides on immune function and their application prospects. | Front Immunol | 2025 | https://conductscience.org/library/papers/41050703 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39486371
GET https://conductscience.org/api/papers/v1/39486371/authors